By activating both receptors simultaneously, tirzepatide produces: More powerful appetite suppression than GLP-1 stimulation alone Greater improvements in insulin sensitivity Larger reductions in body fat, particularly visceral (abdominal) fat Faster and larger HbA1c reductions in people with type 2 diabetes This dual mechanism is the pharmacological reason tirzepatide produces greater weight loss than semaglutide in every major clinical trial conducted to date
An actual internal medicine physician on YouTube leans into the latter quite hard when he says, Please
This dual-receptor approach differentiates mazdutide from earlier GLP-1only medications and reflects a growing trend toward multi-pathway metabolic modulation
If you are tolerating 5mg well and want more aggressive weight loss, this is the natural next step
Since these medicines significantly reduce appetite, every bite becomes more important for meeting your nutritional requirements
This test examines 150+ genetic insights, including GLP-1 receptor sensitivity, appetite regulation, and metabolic efficiencyall factors that shape your ideal dosing timeline